Navigation Links
Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Date:3/18/2008

WALTHAM, Mass., March 18 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming Bank of America 2008 Small and Mid (Smid) Cap Conference being held March 26-27, 2008 at the Four Seasons Hotel in Boston. Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, March 26, 2008 at 8:50 a.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm, or directly through the following link: http://www.veracast.com/webcasts/bas/smidcap08/id88102208.cfm. A replay of the webcast will be available approximately 1 hour after the end of the live event through April 11, 2008. During their presentation Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

Prior to the conference Inverness will also be posting an updated investor presentation to its website at http://www.invmed.com/presentations.cfm.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
2. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
3. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
5. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
6. Inverness Medical Innovations Acquires ParadigmHealth
7. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
8. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
9. Inverness - Chemogen Establish Exclusive License for TB Antibodies
10. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
11. BioMS Medical Announces 2007 Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... MacArthur Sotheby’s International Realty, a ... to announce the first Delos Wellness Signature™ residence in Hawaii is on the ... together with listing agent Kelly Allen, R(S) of Carvill Sotheby’s International Realty located ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
(Date:8/17/2017)... ... August 17, 2017 , ... CNA ... outlet had provided a research update on Aytu Bioscience and cited promising increases ... According to Soulstring, prescription rates for Natesto® have more than doubled since March ...
(Date:8/16/2017)... Ca (PRWEB) , ... August 16, 2017 , ... ... by changing into a different cell type. Many treatments for specific cancers, such ... prominent example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
Breaking Biology Technology:
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... MILAN , March 24, 2017 The Controller ... Deputy Controller Mr. Abdulla Algeen have received the prestigious international ... Continue Reading ... ... small picture) and Deputy Controller Abdulla Algeen (small picture on the right) ...
Breaking Biology News(10 mins):